![Samarth Kulkarni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samarth Kulkarni
Vorstandsvorsitzender bei
CRISPR THERAPEUTICS AG
Vermögen: 14 Mio $ am 30.06.2026
Profil
Samarth Kulkarni ist Vorsitzender von Casebia Therapeutics LLP. Dr. Kulkarni ist auch im Vorstand von Black Diamond Therapeutics, Inc. und Repare Therapeutics, Inc. sowie Centessa Pharmaceuticals Ltd. und Chief Executive Officer & Director bei CRISPR Therapeutics AG und Director-Emerging Companies Section bei Biotechnology Innovation Organization. In der Vergangenheit war Samarth Kulkarni als Partner bei McKinsey & Co, Inc. tätig. Er promovierte an der University of Washington und erwarb einen Bachelor-Abschluss am Indian Institute of Technology New Delhi.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG 0,26 % | 31.03.2026 | 255.501 ( 0,26 % ) | 14 Mio $ | 30.06.2026 |
-.--% | 02.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| 26.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Samarth Kulkarni
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | Vorstandsvorsitzender | 01.12.2017 |
| BLACK DIAMOND THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2019 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Samarth Kulkarni
| Unternehmen | Position | Ende |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 24.06.2026 |
| REPARE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 26.01.2026 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01.07.2015 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Casebia Therapeutics LLP
 Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Provides physical, chemical and analytical testing services | Vorsitzender | - |
Ausbildung von Samarth Kulkarni
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Health Technology |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Provides physical, chemical and analytical testing services | Commercial Services |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Wählen Sie MarketScreener 
